CBT
TAK icon

Capital Bank & Trust’s Takeda Pharmaceutical TAK Stock Holding History

Capital Bank & Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,378
Closed -$97K – 607
2020
Q1 		$97K Buy
6,378
+726
+13% +$13.2K ﹤0.01% 347
2019
Q4 		$112K Hold
5,652
– – ﹤0.01% 357
2019
Q3 		$97K Buy
+5,652
New +$97.8K ﹤0.01% 367

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Capital Bank & Trust's TAK Position: Q2 2020 in Review

Capital Bank & Trust sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 6,378 shares — an estimated $97K sold.

Capital Bank & Trust first reported a position in TAK in Q3 2019 and held it in 3 quarters. The position peaked at $112K in Q4 2019. 309 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

  • Capital Bank & Trust reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 6,378 Takeda Pharmaceutical shares in Q2 2020, an estimated $97K.
  • Capital Bank & Trust first reported a position in Takeda Pharmaceutical in Q3 2019 and held it in 3 quarters.
  • Capital Bank & Trust's Takeda Pharmaceutical position peaked at $112K in Q4 2019.
  • 309 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.